Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02737826 · ClinicalTrials.gov registry record · NA
Discontinuation From Chronic Opioid Therapy For Pain Using a Buprenorphine Taper
A NA study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT02737826 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 32 participants.
The verdict
NCT02737826, a NA study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
Chronic opioid therapy for pain can be associated with significant risks, and a significant number of patients maintained on chronic opioids have continued pain and/or poor functioning. When patients need to or want to come off their opioid pain medications, there is little to guide physicians as to how to best help them do so, and it is not known how patients do after coming off opioid medications. The goals of this study are (1) to evaluate two medications in assisting patients in coming off their opioid pain medications and (2) determining outcomes after discontinuing opioids.
Interventions
- DRUG Buprenorphine Initiation - Phase I
- DRUG Gabapentin + Buprenorphine - Phase II
- DRUG Placebo + Buprenorphine - Phase II
- DRUG Buprenorphine taper - Phase II
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2016-05 |
| Est. Completion | 2021-01-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02737826
The ClinicalTrials.gov registry entry for NCT02737826 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Buprenorphine Initiation - Phase I is the first listed.
NCT02737826 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02737826 about?
NCT02737826 is a clinical study titled "Discontinuation From Chronic Opioid Therapy For Pain Using a Buprenorphine Taper". Chronic opioid therapy for pain can be associated with significant risks, and a significant number of patients maintained on chronic opioids have continued pain and/or poor functioning. When patients need to or want to come off their opioid pain medications, there is little to guide physicians as to...
What is the current status of trial NCT02737826?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2016-05. Estimated completion is 2021-01-13.
What interventions are being tested in trial NCT02737826?
The interventions under investigation include: Buprenorphine Initiation - Phase I (DRUG), Gabapentin + Buprenorphine - Phase II (DRUG), Placebo + Buprenorphine - Phase II (DRUG), Buprenorphine taper - Phase II (DRUG).
Who is sponsoring clinical trial NCT02737826?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.